Divi's Laboratories Limited (NSE:DIVISLAB)
India
· Delayed Price · Currency is INR 6,790.00
+11.50 (0.17%)
Jul 15, 2025, 3:30 PM IST
Divi's Laboratories Market Cap
Divi's Laboratories has a market cap or net worth of 1.80 trillion as of July 15, 2025. Its market cap has increased by 49.13% in one year.
Market Cap
1.80T
Enterprise Value
1.76T
Revenue
93.60B
Ranking
n/a
PE Ratio
82.13
Stock Price
6,790.00
Market Cap Chart
Since March 12, 2003, Divi's Laboratories's market cap has increased from 2.04B to 1.80T, an increase of 88,304.06%. That is a compound annual growth rate of 35.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 1,799.48B | 11.14% |
| Dec 31, 2024 | 1,619.04B | 56.22% |
| Dec 29, 2023 | 1,036.36B | 14.38% |
| Dec 30, 2022 | 906.10B | -27.04% |
| Dec 31, 2021 | 1,241.92B | 21.77% |
| Dec 31, 2020 | 1,019.90B | 108.14% |
| Dec 31, 2019 | Pro | Pro |
| Dec 31, 2018 | Pro | Pro |
| Dec 29, 2017 | Pro | Pro |
| Dec 30, 2016 | Pro | Pro |
| Dec 31, 2015 | Pro | Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,037.12B |
| Cipla | 1,198.64B |
| Mankind Pharma | 1,112.92B |
| Apollo Hospitals Enterprise | 1,038.13B |
| Zydus Lifesciences | 974.49B |
| Aurobindo Pharma | 661.30B |
| Glenmark Pharmaceuticals | 626.26B |
| Fortis Healthcare | 590.60B |